These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31674730)

  • 1. Role of alternative splicing signatures in the prognosis of glioblastoma.
    Xie ZC; Wu HY; Dang YW; Chen G
    Cancer Med; 2019 Dec; 8(18):7623-7636. PubMed ID: 31674730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
    Lai J; Yang H; Xu T
    BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The systematic identification of survival-related alternative splicing events and splicing factors in glioblastoma.
    Peng T; Liu Z; Zhang Y; Liu X; Zhao L; Ma Y; Fan J; Song X; Wang L
    Ann Hum Genet; 2024 Jul; 88(4):320-335. PubMed ID: 38369937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide profiling of alternative splicing in glioblastoma and their clinical value.
    Li Y; Guo D
    BMC Cancer; 2021 Aug; 21(1):958. PubMed ID: 34445990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an epithelial-mesenchymal transition-related lncRNA prognostic signature for patients with glioblastoma.
    Yang X; Niu S; Liu J; Fang J; Wu Z; Ling S; Di G; Jiang X
    Sci Rep; 2021 Dec; 11(1):23694. PubMed ID: 34880375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
    Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Front Oncol; 2020; 10():1257. PubMed ID: 32793502
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
    Wang D; Jiang Y; Wang T; Wang Z; Zou F
    BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
    He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
    Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
    Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
    J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of alternative splicing events and prognostic signatures in breast cancer.
    Han P; Zhu J; Feng G; Wang Z; Ding Y
    BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
    Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
    J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
    Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
    Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
    Duan Y; Zhang D
    J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
    Lei CG; Jia XY; Sun WJ
    Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic alternative splicing signatures in uveal melanoma.
    Xie X; Zheng X; Xie T; Cai J; Yao Y
    Int Ophthalmol; 2021 Apr; 41(4):1347-1362. PubMed ID: 33479809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.